Harvey Jones has been watching this under-the-radar FTSE 100 dividend stock for several years. Suddenly, it's available at a big discount.

ASCO: new Sarclisa data support subcutaneous administration with on-body injector . New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via a ...